midazolam has been researched along with n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Izumi, Y; O'Dell, KA; Tokuda, K; Zorumski, CF | 1 |
1 other study(ies) available for midazolam and n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
Article | Year |
---|---|
Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis.
Topics: Androstenols; Animals; Avoidance Learning; Carrier Proteins; Clonazepam; Excitatory Postsynaptic Potentials; Finasteride; Hippocampus; Indoleacetic Acids; Long-Term Potentiation; Male; Midazolam; Neurons; Neurotransmitter Agents; Pregnanolone; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2010 |